PH24049A - Substituted benzamide derivatives and pharmaceutical compositions containing the same - Google Patents

Substituted benzamide derivatives and pharmaceutical compositions containing the same

Info

Publication number
PH24049A
PH24049A PH35203A PH35203A PH24049A PH 24049 A PH24049 A PH 24049A PH 35203 A PH35203 A PH 35203A PH 35203 A PH35203 A PH 35203A PH 24049 A PH24049 A PH 24049A
Authority
PH
Philippines
Prior art keywords
same
pharmaceutical compositions
compositions containing
benzamide derivatives
substituted benzamide
Prior art date
Application number
PH35203A
Other languages
English (en)
Inventor
Tatsuya Kon
Shiro Kato
Toshiya Morie
Kazunori Ohno
Tadahiko Karasawa
Naoyuki Yoshida
Katsuhiko Hino
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of PH24049A publication Critical patent/PH24049A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/10Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
PH35203A 1986-04-30 1987-04-29 Substituted benzamide derivatives and pharmaceutical compositions containing the same PH24049A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10155286 1986-04-30
JP31509086 1986-12-31

Publications (1)

Publication Number Publication Date
PH24049A true PH24049A (en) 1990-03-05

Family

ID=26442419

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35203A PH24049A (en) 1986-04-30 1987-04-29 Substituted benzamide derivatives and pharmaceutical compositions containing the same

Country Status (18)

Country Link
US (1) US4870074A (h)
EP (1) EP0243959B1 (h)
KR (1) KR870010030A (h)
AR (1) AR242953A1 (h)
AU (1) AU592177B2 (h)
CA (1) CA1291135C (h)
CZ (1) CZ284687B6 (h)
DE (1) DE3781195T2 (h)
DK (1) DK175281B1 (h)
ES (1) ES2043617T3 (h)
FI (1) FI87776C (h)
GR (1) GR3005934T3 (h)
HK (1) HK18194A (h)
HU (1) HU198193B (h)
NZ (1) NZ220120A (h)
PH (1) PH24049A (h)
SK (1) SK279058B6 (h)
SU (1) SU1597101A3 (h)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
TW213460B (h) * 1991-02-15 1993-09-21 Hokuriku Pharmaceutical
US5395832A (en) * 1991-02-15 1995-03-07 Hokuriku Seiyaku Co., Ltd. Benzamide derivatives
US5864039A (en) * 1994-03-30 1999-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and use thereof as medicaments
CA2186623A1 (en) * 1994-03-30 1995-10-21 Takeshi Kawakita Benzoic acid compound and use thereof as medicine
DE69617001T2 (de) * 1995-05-23 2002-07-11 Janssen Pharmaceutica N.V., Beerse (2-morpholinylmethyl)benzamid-derivate
JP2001064177A (ja) * 1999-08-16 2001-03-13 Schering Ag ベンズアミド誘導体を有効成分とする製剤
JP5089846B2 (ja) * 2000-09-29 2012-12-05 グラクソ グループ リミテッド 炎症性疾患を処置するためのモルホリン−アセトアミド誘導体
ES2234929T3 (es) * 2000-11-28 2005-07-01 Smithkline Beecham Plc Derivados de morfolina como antagonistas de los receptores de orexina.
JP4829417B2 (ja) * 2001-03-26 2011-12-07 明夫 乾 インスリン抵抗性改善薬
US20040265381A1 (en) * 2001-10-08 2004-12-30 Shanghvi Dilip S. Anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma
GB0207447D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
GB0207449D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
GB0208158D0 (en) * 2002-03-28 2002-05-22 Glaxo Group Ltd Novel compounds
HUP0201980A3 (en) * 2002-06-13 2008-06-30 Richter Gedeon Nyrt Process for preparing a benzamide derivative and intermediates thereof
US8153161B2 (en) * 2003-12-09 2012-04-10 Dainippon Sumitomo Pharma Co., Ltd. Medicament-containing particle and a solid preparation containing the particle
US8138204B2 (en) * 2004-01-07 2012-03-20 Aryx Therapeutics, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
EP1704146B1 (en) * 2004-01-07 2010-04-14 Aryx Therapeutics Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US8524736B2 (en) 2004-01-07 2013-09-03 Armetheon, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
PT1801108E (pt) * 2004-09-08 2012-12-03 Mitsubishi Tanabe Pharma Corp Composto de morfolina para o tratamento de inflamações
TWI391380B (zh) * 2005-06-23 2013-04-01 Array Biopharma Inc 製備苯并咪唑化合物之方法
US7326787B2 (en) * 2005-08-31 2008-02-05 Aryx Therapeutics, Inc. Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders
US20090042926A1 (en) * 2005-12-20 2009-02-12 Jason Imbriglio Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
KR100750593B1 (ko) * 2006-03-16 2007-08-20 동우신테크 주식회사 치환된 벤즈아미드 유도체의 제조방법
US20080085915A1 (en) * 2006-06-23 2008-04-10 Cyrus Becker Compounds and methods for the treatment of gastrointestinal and central nervous system disorders
ES2524340T3 (es) * 2007-04-19 2014-12-05 Concert Pharmaceuticals Inc. Compuestos de morfinilino deuterados
CN101402633A (zh) * 2007-09-11 2009-04-08 上海恒瑞医药有限公司 苯甲酰胺类衍生物、其制备方法及其在医药上的用途
ES2393640T3 (es) 2008-02-13 2012-12-26 Dainippon Sumitomo Pharma Co., Ltd. Comprimidos bucodisgregables
TWI423967B (zh) * 2008-02-21 2014-01-21 Dainippon Sumitomo Pharma Co 醯胺衍生物及含有其之醫藥組合物
US8591955B2 (en) 2009-08-11 2013-11-26 Dainippon Sumitomo Pharma Co., Ltd. Orally rapidly disintegrating tablet that contains two or more types of particles
WO2011107903A1 (en) 2010-03-04 2011-09-09 Ranbaxy Laboratories Limited Highly pure mosapride citrate dihydrate and processes for its preparation
MX336155B (es) 2011-02-25 2016-01-07 Yuhan Corp Derivados de diaminopirimidina y procesos para su preparacion.
KR101657616B1 (ko) 2013-05-24 2016-09-19 주식회사유한양행 피리미딘 고리를 포함하는 바이사이클릭 유도체 및 그의 제조방법
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Hdac抑制劑與pd-l1抑制劑之組合治療
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
CN111349052B (zh) * 2020-04-07 2021-02-12 福建海西新药创制有限公司 一种枸橼酸莫沙必利的合成方法
CN114560822B (zh) * 2020-11-27 2024-05-28 鲁南制药集团股份有限公司 一种莫沙必利的二羧酸晶体
CN114591260B (zh) * 2020-12-05 2025-07-11 鲁南制药集团股份有限公司 一种莫沙必利有机酸盐
CN119241464A (zh) * 2024-10-22 2025-01-03 吉林修正药业新药开发有限公司 一种枸橼酸莫沙必利杂质化合物及其制备方法
CN119241463A (zh) * 2024-10-22 2025-01-03 吉林修正药业新药开发有限公司 一种枸橼酸莫沙必利杂质化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH451142A (de) * 1965-01-19 1968-05-15 Sandoz Ag Verfahren zur Herstellung neuer basisch substituierter Benzoesäureamide
US4029786A (en) * 1972-08-11 1977-06-14 Imperial Chemical Industries Limited Morpholine derivatives for treating depression
US4323503A (en) * 1976-08-04 1982-04-06 Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France Substituted 2,3-alkylene di (oxy) benzamides and derivatives
US4210754A (en) * 1977-02-01 1980-07-01 Hoffmann-La Roche Inc. Morpholino containing benzamides
US4692445A (en) * 1983-04-29 1987-09-08 Rorer Pharmaceutical Corporation Bicyclic benzenoid aminoalkylene ethers and thioethers, pharmaceutical compositions and use
FR2575158B1 (fr) * 1984-12-20 1987-10-02 Pf Medicament Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
JPH0390274A (ja) * 1989-08-28 1991-04-16 Furukawa Alum Co Ltd Al又はAl合金の気相ろう付法

Also Published As

Publication number Publication date
SU1597101A3 (ru) 1990-09-30
DK218787A (da) 1987-10-31
KR870010030A (ko) 1987-11-30
ES2043617T3 (es) 1994-01-01
US4870074A (en) 1989-09-26
FI871828A0 (fi) 1987-04-27
DK175281B1 (da) 2004-08-09
NZ220120A (en) 1989-06-28
FI871828A7 (fi) 1987-10-31
EP0243959A1 (en) 1987-11-04
DK218787D0 (da) 1987-04-29
AR242953A1 (es) 1993-06-30
SK289787A3 (en) 1998-06-03
CZ284687B6 (cs) 1999-02-17
CZ289787A3 (cs) 1998-11-11
FI87776B (fi) 1992-11-13
HK18194A (en) 1994-03-11
AU7227587A (en) 1987-11-05
DE3781195T2 (de) 1993-02-18
GR3005934T3 (h) 1993-06-07
HU198193B (en) 1989-08-28
FI87776C (fi) 1993-02-25
DE3781195D1 (de) 1992-09-24
EP0243959B1 (en) 1992-08-19
SK279058B6 (sk) 1998-06-03
AU592177B2 (en) 1990-01-04
CA1291135C (en) 1991-10-22
HUT45514A (en) 1988-07-28

Similar Documents

Publication Publication Date Title
PH24049A (en) Substituted benzamide derivatives and pharmaceutical compositions containing the same
NZ220345A (en) Imidazoquinolinylether derivatives and pharmaceutical compositions containing them
NZ220880A (en) Di-tert-butyl-phenol derivatives and pharmaceutical compositions
NZ222980A (en) 3-aryloxy-3-substituted propanamines and pharmaceutical compositions
NZ223096A (en) Peptidylaminodiols and pharmaceutical compositions
IL82221A0 (en) Phenyl-piperazines and pharmaceutical compositions containing them
NZ216793A (en) Phenethanolaminotetraline derivatives and pharmaceutical compositions
PH22014A (en) Heterocyclic derivatives and pharmaceutical compositions containing the same
NZ221996A (en) Imidazo-pyridine derivatives and pharmaceutical compositions
IL72566A (en) Androst-5-en-17-one and 5alpha-androstan-17-one derivatives and pharmaceutical compositions containing the same
NZ220171A (en) Dihydro-benzopyran derivatives and pharmaceutical compositions
NZ212499A (en) Substituted benzamide derivatives and pharmaceutical compositions
IL82205A (en) Substituted alkane-sulfonamidophenyl derivatives and pharmaceutical compositions containing them
IL79376A (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
PH21540A (en) Cholecalciferol derivatives and pharmaceutical compositions containing the same
IL72515A0 (en) Coumarin deerivatives and pharmaceutical compositions containing the same
IL72562A (en) 6,7-dimethoxy-4-piperidino-quinazoline derivatives and pharmaceutical compositions containing them
NZ217078A (en) N-piperidyl-benzamide derivatives and pharmaceutical compositions
PH22941A (en) Phenethanolamine derivatives and pharmaceutical compositions containing the same
IL79583A (en) Androsterone derivatives and pharmaceutical compositions containing the same
NZ216720A (en) Diazinylpiperidine derivatives and pharmaceutical compositions
NZ223051A (en) Carbamoyloxylabdane derivatives and pharmaceutical compositions
PH19575A (en) Cephalosporing derivatives and pharmaceutical compositions thereof
NZ214284A (en) Benzamide derivatives and pharmaceutical compositions
PH23398A (en) Indenopyrimidine derivatives and pharmaceutical formulation containing the same